Anika Therapeutics to Log $5MM Milestone Payment for MONOVISC

Anika Therapeutics (ANIK) will receive a US $5MM milestone payment per terms of the MONOVISC® license agreement with U.S. commercial partner, DePuy Mitek. The payment was triggered by $100.0MM in U.S. end-user sales within a consecutive 12-month period at the end of 2Q17.

MONOVISC remains the company's main growth driver. For 1Q17,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us